Transcription factor Yin Yang 1 enhances epithelial-mesenchymal transition, migration, and stemness of non-small cell lung cancer cells by targeting sonic hedgehog

被引:1
作者
Huang, Tonghai [1 ]
Ren, Kangqi [1 ]
Ling, Xiean [1 ]
Li, Zeyao [1 ]
Chen, Lin [1 ]
机构
[1] Southern Univ Sci & Technol 2, Clin Med Coll Jinan Univ,Affiliated Hosp 1, Shenzhen Peoples Hosp, Dept Thorac Surg, 1017,East Gate Rd, Shenzhen 518020, Guangdong, Peoples R China
关键词
NSCLC; YY1; Shh; EMT; Stemness; MICROENVIRONMENT;
D O I
10.1007/s11010-024-05104-y
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Non-small cell lung cancer (NSCLC) is a frequent type of lung cancer. Transcription factor Yin Yang 1 (YY1), an endogenous transcription factor containing zinc finger structure, can accelerate NSCLC progression. However, the impact of YY1 on the stemness of NSCLC cells and the mechanism of promoting NSCLC cell progression is unclear. YY1 and Sonic hedgehog (Shh) expressions were monitored by RT-qPCR, western blot, and immunohistochemistry. Overall survival was tested through Kaplan-Meier analysis. The interaction between YY1 and Shh was confirmed. Then, cell migration, stemness, and epithelial-mesenchymal transition (EMT) were assessed with functional experiments in vitro and in vivo. YY1 and Shh were highly expressed in NSCLC tissues and positively correlated with the poor OS of NSCLC patients. Functional experiments denoted that YY1 or Shh overexpression could accelerate EMT, migration, and stemness of NSCLC cells, and YY1 or Shh knockdown played the opposite role to its overexpression. Mechanism analysis disclosed that Shh, as a target gene of YY1, was positively related to YY1. The rescued experiment manifested that Shh silencing could reverse the induction effect of YY1 overexpression on EMT, migration, and stemness of NSCLC cells. In vivo experiments also confirmed that YY1 could accelerate tumor growth and EMT and weaken apoptosis. YY1 promotes NSCLC EMT, migration, and stemness by Shh, which might be novel diagnostic markers and therapeutic targets for NSCLC therapy.
引用
收藏
页码:1831 / 1843
页数:13
相关论文
共 50 条
[21]   The role of miR-6884-5p in epithelial-mesenchymal transition in non-small cell lung cancer [J].
Zhang, Lianyong ;
Chi, Wei ;
Wang, Xue ;
Li, Jingjing ;
Li, Fei ;
Ma, Yuxia ;
Zhang, Qianyun .
AGING-US, 2024, 16 (02) :1968-1979
[22]   Withaferin A inhibits Epithelial to Mesenchymal Transition in Non-Small Cell Lung Cancer Cells [J].
Kyakulaga, Al Hassan ;
Aqil, Farrukh ;
Munagala, Radha ;
Gupta, Ramesh C. .
SCIENTIFIC REPORTS, 2018, 8
[23]   Transcription factor glioma-associated oncogene homolog 1 is required for transforming growth factor-β1-induced epithelial-mesenchymal transition of non-small cell lung cancer cells [J].
Li, Hua ;
Da, Li-Jun ;
Fan, Wei-Dong ;
Long, Xiao-Hong ;
Zhang, Xian-Quan .
MOLECULAR MEDICINE REPORTS, 2015, 11 (05) :3259-3268
[24]   MiR-940 inhibits TGF-β-induced epithelial-mesenchymal transition and cell invasion by targeting Snail in non-small cell lung cancer [J].
Jiang, Kanqiu ;
Zhao, Ting ;
Shen, Mingjing ;
Zhang, Fuquan ;
Duan, Shanzhou ;
Lei, Zhe ;
Chen, Yongbing .
JOURNAL OF CANCER, 2019, 10 (12) :2735-2744
[25]   SATB1 protein is associated with the epithelial-mesenchymal transition process in non-small cell lung cancers [J].
Glatzel-Plucinska, Natalia ;
Piotrowska, Aleksandra ;
Rzechonek, Adam ;
Podhorska-Okolow, Marzenna ;
Dziegiel, Piotr .
ONCOLOGY REPORTS, 2021, 45 (06)
[26]   FOXC2 promotes epithelial-mesenchymal transition and cisplatin resistance of non-small cell lung cancer cells [J].
He, Yuwen ;
Xie, Hui ;
Yu, Pengjiu ;
Jiang, Shunjun ;
Wei, Li .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (06) :1049-1059
[27]   Detection of PD-L1 expression and epithelial-mesenchymal transition of circulating tumor cells in non-small cell lung cancer [J].
Jiang, Jianping ;
Mo, Weiqiang ;
Lian, Xue ;
Cao, Dakui ;
Cheng, Haiying ;
Wang, Haiqin .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2024, 28 (01)
[28]   Mechanism of epithelial-mesenchymal transition inhibited by miR-203 in non-small cell lung cancer [J].
Huang, Weicong ;
Wu, Yuanbo ;
Cheng, Dezhi ;
He, Zhifeng .
ONCOLOGY REPORTS, 2020, 43 (02) :437-446
[29]   Modelling reoxygenation effects in non-small cell lung cancer cell lines and showing epithelial-mesenchymal transition [J].
Kapeleris, Joanna ;
Bark, Juliana Muller ;
Ranjit, Shanon ;
Richard, Derek ;
Vela, Ian ;
O'Byrne, Kenneth ;
Punyadeera, Chamindie .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (12) :3501-3510
[30]   Knockdown of TRIM66 inhibits malignant behavior and epithelial-mesenchymal transition in non-small cell lung cancer [J].
Dai, Huan-yu ;
Ma, Yan ;
Zhao, Da ;
Hou, Xiao-ming .
PATHOLOGY RESEARCH AND PRACTICE, 2018, 214 (08) :1130-1135